Announcements Trials
Browse Landscape

Phase

Phase NA 8Phase 3 7Phase 4 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6Genitourinary 5Gastrointestinal 5Lymphoid 4Thoracic 2Sarcoma 2Other 2Head & Neck 2Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Endocrine 1

Conditions

Multiple Myeloma 52Neoplasms, Plasma Cell 5Neoplasms 4Lymphoma 4Waldenstrom Macroglobulinemia 3Recurrence 3Hematologic Neoplasms 3Prostatic Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Breast Neoplasms 2Bone Neoplasms 2Back Pain 2Venous Thromboembolism 1Stomatitis 1Skin Neoplasms 1Renal Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumococcal 1Pneumococcal Infections 1Peripheral Nervous System Diseases 1Pain 1Osteoporosis 1Osteonecrosis 1Osteolysis 1Myeloproliferative Disorders 1Multiple Sclerosis 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1

Interventions

Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pain × Plasma cell × Clear all
NCT00029224 2012-02-01

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions

Novartis

Phase 4 Completed
500 enrolled
BreastGenitourinaryPlasma cell

Breast Neoplasms, Multiple Myeloma, Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡